期刊文献+

阿托伐他汀强化治疗对冠心病患者外周血管易损斑块的影响 被引量:10

原文传递
导出
摘要 目的观察阿托伐他汀联合阿司匹林控制冠心病患者周围血管易损斑块的效果。方法冠心病患者68例随机分为常规剂量阿托伐他汀治疗组(对照组)与强化阿托伐他汀治疗组(观察组)各34例,2组均给予阿司匹林肠溶片100mg/次,1次/d,口服,对照组给予阿托伐他汀20 mg/次,1次/d,睡前口服;观察组给予阿托伐他汀40 mg/次,1次/d,睡前口服。2组均连续服用24个月,观察2组治疗前、后颈总动脉内径(common carotid artery diameter,CCAD)、颈动脉内-中膜厚度(carotid intima-media thickness,CIMT)、斑块体积及血脂变化情况。结果 2组治疗24个月后CCAD较治疗前增加(P<0.05),高密度脂蛋白胆固醇水平较治疗前增高(P<0.05),CIMT、斑块体积及三酰甘油、胆固醇、低密度脂蛋白胆固醇水平均较治疗前降低(P<0.05),观察组各指标改善较对照组明显(P<0.05)。结论阿托伐他汀联合阿司匹林肠溶片可稳定冠心病患者颈动脉易损斑块,控制血脂水平,强化治疗效果优于常规剂量治疗。
出处 《中华实用诊断与治疗杂志》 2013年第10期1007-1009,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 四川省教育厅重点项目(08zc061)
  • 相关文献

参考文献4

二级参考文献79

  • 1陈燕,常志文.冠心病患者血中白介素-6和白介素-10浓度的变化──附46例检测报告[J].新医学,2004,35(7):413-414. 被引量:20
  • 2徐军霞,张冬梅,姚俊华,祝梅华.不同剂量阿托伐他汀治疗颈动脉粥样硬化斑块的临床观察[J].中华高血压杂志,2006,14(9):753-754. 被引量:14
  • 3张震.高密度脂蛋白(HDL)和甘油三酯作为治疗的靶点[J].中国分子心脏病学杂志,2003,3(5):296-304. 被引量:22
  • 4Mirkhel A,Peyster E,Sundeen J,Greene L,Michelson AD,Hasan A,et al.Frequency of aspirin resistance in a community hospital.Am J Cardiol 2006; 98:577-579.
  • 5Bliden KP,Dichiara J,Lawal L,Singla A,Antonino MJ,Baker BA,et al.The association of cigarette smoking with enhanced platelet inhibition by clopidogrel.J Am Coll Cardiol 2008; 52:531-533.
  • 6Gurbel PA,Bliden KP,Hiatt BL,O'Connor CM.Clopidogrel for coronary stenting:response variability,drug resistance,and the effect of pretreatment platelet reactivity.Circulation 2003; 107:2908-2913.
  • 7Matetzky S,Shenkman B,Guetta V,Shechter M,Bienart R,Goldenberg I,et al.Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.Circulation 2004; 109:3171-3175.
  • 8Patrignani P,Filabozzi P,Patrono C.Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects.J Clin Invest 1982; 69:1366-1372.
  • 9FitzGerald GA,Oates JA,Hawiger J,Maas RL,Roberts LJ,Lawson JA,et al.Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.J Clin Invest 1983; 71:676-688.
  • 10Reilly IA,FitzGerald GA.Inhibition of thromboxane formation in vivo and ex vivo:implications for therapy with platelet inhibitory drugs.Blood 1987; 69:180-186.

共引文献89

同被引文献100

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33100
  • 2Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta- analysis[J]. Circulation, 2007, 115(4):459-467.
  • 3Goldstein LB1, Amareneo P, Zivin J, et al. Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels(SPARCL) trial[J]. Stroke, 2009, 40(11):3526-353.
  • 4Flint AC, Kamel H, Navi BB, et al. Slatin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival[J]. Stroke, 2012,43(1): 147-154.
  • 5Senechal M, MacHaalany J, Bertrand OF, et al, Predictors of left ventricular remodeling after surgical repair or replacement for pure severe mitral regurgitation caused by leaflet prolapse [J]. Am J Cardiol,2013,112(4) :567-573.
  • 6A1 Rifai M, Silverman MG, Nasir K, et al. The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA)[J]. Atherosclerosis,2015,239(2) :629-633.
  • 7Kim SH, Chung JH, Kwon BJ, et al. The associations of epicardial adipose tissue with coronary artery disease and coronary atherosclerosis[J]. Int Heart J, 2013,55 (3) : 197-203.
  • 8Shimabukuro M, Hirata Y, Tabata M, etal. Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 2013,33 (5) : 1077-1084.
  • 9Shehzad A, Ha T, Subhan F, et al. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases[J]. Eur J Nutr,2011,50(3):151-161.
  • 10Wang J, Wang LJ, Peng YP, et al. Association of pericardial adipose tissue volume with presence and severity of coronary atherosclerosis[J]. Clin Invest Med,2013,36(3) :E143-E150.

引证文献10

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部